Euthymics Bioscience Secures $7,500,273 New Funding

  • Feed Type
  • Date
    4/2/2014
  • Company Name
    Euthymics Bioscience
  • Mailing Address
    43 Thorndike St. Cambridge, MA 02141 USA
  • Company Description
    Euthymics Bioscience, Inc. is a neuroscience-focused clinical-stage company developing next-generation treatments for depression. Euthymics’ initial focus is on patients who do not respond adequately to SSRIs.
  • Website
    http://www.euthymics.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $7,500,273
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities.
  • M&A Terms
  • Venture Investor